ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1512

Is Sacroiliac Imaging the All-Decisive Factor in the Diagnosis of Early Axial Spondyloarthritis? Data from the Spondyloarthritis Caught Early (SPACE) Cohort

Zineb Ez-Zaitouni1, Robert B.M. Landewé2, Miranda van Lunteren1, Pauline Bakker1, Karen M Fagerli3, Roberta Ramonda4, Lennart TH Jacobsson5, Désirée van der Heijde6 and Floris van Gaalen7, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Amsterdam Rheumatology & Immunology Center, Amsterdam, Netherlands, 3Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 4Rheumatology Unit, University of Padova, Padova, Italy, 5Department of Rheumatology and Inflammation Research, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden, 6Leiden University Medical Center, Leiden, Netherlands, 7Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Ankylosing spondylitis (AS), axial spondyloarthritis and diagnostic imaging, Imaging

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Spondyloarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Imaging of the sacroiliac joints plays a pivotal role in the recognition of axSpA. However, interpretation of imaging is challenging and has led to concerns of overreliance on imaging possibly leading to incorrect diagnoses of axSpA. Given these controversies, surprisingly little is known about how rheumatologists actually integrate sacroiliac imaging results in the diagnostic work-up of patients suspected of axSpA. Therefore, we evaluated the influence of sacroiliac imaging on diagnosis and rheumatologists’ confidence in diagnosis of patients with chronic back pain (CBP) suspected of early axSpA.

Methods:

Baseline data from 513 patients from the SPACE cohort which includes patients with CBP (≥3 months, ≤2 years, onset <45 years) were analysed. All patients underwent a full work-up including MRI and radiography of the sacroiliac joints. Rheumatologists were asked to provide a diagnosis before and after taking imaging into account. Also, a level of confidence (LoC) regarding the diagnosis on an 11-point numerical scale (0: not confident at all to 10: very confident) was documented.

Results:

Before imaging, 317/513 (62%) CBP patients were diagnosed with axSpA. Of these patients, 178/317 (56%) did not have sacroiliitis on MRI or radiography, and after imaging rheumatologists changed diagnosis to ‘no axSpA’ in 81/178 (46%) patients. Of the patients without axSpA before imaging, 35/196 (18%) had sacroiliitis on imaging. After imaging, 28/35 (80%) patients were diagnosed with axSpA and in 7/35 (20%) patients the diagnosis remained ‘no axSpA’ In general, diagnostic confidence increased significantly following imaging (all patients’ average LoC 6.2 to 7.4, p<0.001). Overall, imaging results not in line with the diagnosis (n=213) before imaging led to a change in diagnosis in 109 (51%) patients.

Conclusion:

In CBP patients suspected of axSpA sacroiliac imaging increases diagnostic confidence. However, the number of changes in diagnosis suggests that imaging is an important but not the all-decisive factor in axSpA diagnosis.



Disclosure: Z. Ez-Zaitouni, None; R. B. M. Landewé, None; M. van Lunteren, None; P. Bakker, None; K. M. Fagerli, None; R. Ramonda, None; L. T. Jacobsson, None; D. van der Heijde, None; F. van Gaalen, None.

To cite this abstract in AMA style:

Ez-Zaitouni Z, Landewé RBM, van Lunteren M, Bakker P, Fagerli KM, Ramonda R, Jacobsson LT, van der Heijde D, van Gaalen F. Is Sacroiliac Imaging the All-Decisive Factor in the Diagnosis of Early Axial Spondyloarthritis? Data from the Spondyloarthritis Caught Early (SPACE) Cohort [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/is-sacroiliac-imaging-the-all-decisive-factor-in-the-diagnosis-of-early-axial-spondyloarthritis-data-from-the-spondyloarthritis-caught-early-space-cohort/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-sacroiliac-imaging-the-all-decisive-factor-in-the-diagnosis-of-early-axial-spondyloarthritis-data-from-the-spondyloarthritis-caught-early-space-cohort/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology